Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh - Full Text View

Sponsor:	Johns Hopkins Bloomberg School of Public Health
Collaborator:	Dhaka Shishu Hospital
Information provided by:	Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:	NCT00844337

Purpose

The primary aim is to establish the non-inferiority of several simplified, home-based antibiotic regimens compared to the standard course of parenteral antibiotics for the empiric treatment of suspected sepsis in Bangladeshi young infants whose parents refuse hospitalization. Three alternative regimens will be compared with a standard (reference) regimen of injectable procaine-benzyl penicillin and gentamicin once daily each for seven days. Alternative regimens are (1) injectable gentamicin once daily and oral amoxicillin twice daily for seven days; (2) injectable penicillin and gentamicin once daily for two days followed by oral amoxicillin twice daily for five days; and (3) injectable gentamicin once daily and oral amoxicillin twice daily for two days followed by oral amoxicillin twice daily for five days.

Hypothesis

The proportion who fails treatment will be 10 percent in the reference group and the alternative treatment groups. An alternative therapy will be considered non-inferior to the standard therapy if the failure rate in the alternative therapy exceeds the failure rate in the injectable therapy by less than 5 absolute percentage points.

Secondary Objectives:

To identify baseline clinical predictors of treatment failure in severe infections in young infants.
To determine the proportion of relapse (young infants who were considered cured by day 7 but developed any of the signs of suspected severe infection by day 14).

Condition	Intervention
Sepsis	Drug: Gentamicin & Amoxicillin x 7days Drug: Penicillin & gentamicin x 2 d + Amoxicillin X 5 d Drug: Standard reference therapy

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
Official Title:	Safety and Efficacy of Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh

Resource links provided by NLM:

MedlinePlus related topics: Antibiotics Sepsis

Drug Information available for: Amoxicillin Amoxicillin sodium Amoxicillin trihydrate Gentamicins Penicillins

U.S. FDA Resources

Further study details as provided by Johns Hopkins Bloomberg School of Public Health:

Primary Outcome Measures:

Treatment failure [ Time Frame: Seven days ] [ Designated as safety issue: Yes ]

Estimated Enrollment:	2400
Study Start Date:	March 2009
Estimated Study Completion Date:	September 2011
Estimated Primary Completion Date:	September 2011 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Active Comparator Injectable gentamicin once daily and oral amoxicillin twice daily for seven days	Drug: Gentamicin & Amoxicillin x 7days Injectable gentamicin once daily and oral amoxicillin twice daily for seven days. The dose for gentamicin is 4 - 5 mg/kg/24 hours. The dose for amoxicillin is 90-115 mg/kg/day.
2: Active Comparator Injectable penicillin and gentamicin once daily for two days followed by oral amoxicillin twice daily for five days	Drug: Penicillin & gentamicin x 2 d + Amoxicillin X 5 d Injectable penicillin and gentamicin once daily for two days followed by oral amoxicillin twice daily for five days. The dose for penicillin is 40,000 - 50,000 U/kg/24 hours, the dose for gentamicin is 4 - 5 mg/kg/24 hours, and the dose for amoxicillin is 90-115 mg/kg/day.
3: Active Comparator Injectable procaine-benzyl penicillin and gentamicin once daily each for seven days (COMPARISON ARM)	Drug: Standard reference therapy Injectable procaine-benzyl penicillin and gentamicin once daily each for seven days. The penicillin dose is 40,000 - 50,000 U/kg/24 hours, and the gentamicin dose is 4 - 5 mg/kg/24 hours.

Show Detailed Description

Eligibility

Ages Eligible for Study:	up to 59 Days
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Infants 0-59 days old who are residents of catchment population of the study hospitals
One or more of the following five signs: severe chest in-drawing, axillary temperature >37.80C or <35.50 C, lethargic or less than normal movement, and history of feeding problems (confirmed by poor suck on feeding assessment)
Family refuses recommended hospitalization or hospitalization otherwise not feasible
Informed consent by a legal guardian.

Exclusion Criteria:

Very severe infection/disease characterized by presence of any of the following signs (unconscious, convulsions, unable to feed, apnea, unable to cry, cyanosis, bulging fontanel, major congenital malformations, major bleeding, surgical conditions needing hospital referral, persistent vomiting defined as vomiting following three attempts to feed the baby within ½ hour, and/or physician's suspicion of meningitis)
Very low birth weight: weight <1500
Hospitalization for illness in the last two weeks
Hospital born infants
Previous inclusion in the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00844337

Contacts

Contact: Abdullah H Baqui, MBBS DrPH MPH

410-955-3850

abaqui@jhsph.edu

Locations

Bangladesh
Chittagong Ma O Shishu Hospital	Recruiting
Chittagong, Bangladesh
Contact: Wazir Ahmed, MBBS 88031711236
Shishu Shastya Foundation	Recruiting
Dhaka, Bangladesh
Contact: AFM Selim, MBBS 01711606701
Bangladesh, Dhaka
	Recruiting
Dhaka Shishu Hospital/CHRF, Dhaka, Bangladesh, 1216
Contact: Samir K Saha, PhD 880280238945

Sponsors and Collaborators

Johns Hopkins Bloomberg School of Public Health

Dhaka Shishu Hospital

Investigators

Principal Investigator:

Abdullah H Baqui, MBBS DrPH MPH

Johns Hopkins University Bloomberg School of Public Health

More Information

No publications provided

Responsible Party:	Johns Hopkins Bloomberg School of Public Health ( Dr. Abdullah H. Baqui, Associate Professor )
Study ID Numbers:	JHU IRB 1440, USAID GHS-A-00-03-00019-00
Study First Received:	February 13, 2009
Last Updated:	October 19, 2009
ClinicalTrials.gov Identifier:	NCT00844337 History of Changes
Health Authority:	United States: Institutional Review Board; Bangladesh: Ethical Review Committee; Switzerland: World Health Organization Ethical Review Committee

Keywords provided by Johns Hopkins Bloomberg School of Public Health:

antibiotic regimens
sepsis
young infants

Bangladeshi
outpatient treatment
Suspected sepsis in young infants

Additional relevant MeSH terms:

Systemic Inflammatory Response Syndrome
Anti-Infective Agents
Amoxicillin
Molecular Mechanisms of Pharmacological Action
Enzyme Inhibitors
Infection
Pharmacologic Actions

Inflammation
Anti-Bacterial Agents
Protein Synthesis Inhibitors
Sepsis
Pathologic Processes
Therapeutic Uses
Gentamicins

ClinicalTrials.gov processed this record on February 08, 2010